ABSTRACT
During the COVID-I9 crisis, teaching and learning activities were largely conducted online through open and distance learning (ODL). As a result, educators and students lacked the personal warmth and emotional support usually found in face-to-face classes, which affected the quality of the teaching and learning process. Therefore, what could educators do to facilitate the teaching and learning process during the pandemic? This chapter features narratives on humanistic practices in teaching that were carried out during the pandemic by five university lecturers. The narratives shed light on how they embedded humanistic elements in either one or several of these aspects of teaching: delivery, content, consultation, and assessment. Their pedagogical approaches indicate that education is not a rigid domain, but it can be extended beyond the four walls of the classroom and executed from the sincere heart. © 2023 by IGI Global. All rights reserved.
ABSTRACT
Background and Aims: The social restrictions in COVID- 19 pandemic can affect to patient's asthma status. The use of telecommunications by the physician to know the patient's asthma status during pandemic is recommended. This study aims to determine patient's asthma status before the COVID-19 pandemic compared to one year after. Methods: This preliminary study was a retrospective cohort which was conducted in March of 2020 and March of 2021 at Asthma Polyclinic, Persahabatan Hospital, Jakarta. The subjects were asthma patients who visited Asthma Polyclinic in March of 2020 and requires an ACT score. Patients who didn't come to Asthma Polyclinic in March of 2021 will be contacted by the researchers. Results: The ACT score in March of 2020 are 6% patients had fully controlled asthma, 34% of partial controlled asthma and 60% of uncontrolled asthma while in March of 2021, 26% have fully controlled asthma, 26% of partial controlled asthma and 48% of uncontrolled asthma. There was a significant difference between ACT score in March of 2020 and March of 2021 with a p value 0.020. The patient's activities during pandemic was decreasing, 80% patients who didn't work, while 20% were still working. There was a significant difference between patient's severity of asthma and ACT score in March of 2021 with a p value <0,05. Conclusion: There is a significant difference between the ACT score in March of 2020 and March of 2021, also a significant difference between patient's severity of asthma and ACT score in March of 2021.
ABSTRACT
Background and Aim: The outbreak of Coronavirus disease 2019 (COVID-19) has spread worldwide with the growing number of confirmed cases and deaths. Acute myocardial injury is one of the most common clinical manifestations in COVID-19 patients, results in higher risk of morbidity and mortality. However, the prevalence of acute myocardial injury in COVID-19 patients is not well documented. This study aimed to assess the prevalence of acute myocardial injury in COVID-19 patients. Methods: A cross-sectional study utilizing medical record was done on COVID-19 patients admitted to Persahabatan hospital, Jakarta, within the period of June to December 2020. The prevalence of acute myocardial injury was assessed through high sensitivity Troponin I (hsTrop-I) levels examination. The association of cardiovascular disease comorbidities and levels of inflammatory biomarkers with acute myocardial injury were also determined. Results: From a total of 340 patients enrolled in the study, 58 (17.1%) patients experienced acute myocardial injury, in which majority (58.6%) aged >40 years. The prevalence of acute myocardial injury was more dominant in patients with cardiovascular disease comorbidities (63.8%) and critically ill COVID-19 patients (37.9%). Procalcitonin levels showed significant association with acute myocardial injury (p<0.01). Conclusion: The prevalence of acute myocardial injury in COVID-19 patients in Persahabatan Hospital was pretty high (17.1%). Acute myocardial injury was significantly associated with procalcitonin levels and cardiovascular comorbidities.
ABSTRACT
Background: Acute respiratory illness caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) involved the whole globe within no time. Various studies published globally have shown variable severity of disease and mortality. The objective of our study was to describe clinical and epidemiological characteristics of the disease in our setup. Methods: in this descriptive case series, individuals with signs and symptoms of Coronavirus disease-19 (COVID-19) and asymptomatic patients with history of close contact to confirmed COVID-19 patients were considered for SARS-CoV-2 Polymerase chain reaction (PCR) assay. Epidemiological and clinical features of only PCR positive cases were recorded. Data regarding hospitalization status, exposure to known COVID-19 patients, clinical feature and clinical outcome of patients was collected and interpreted. Results: A total of 266 patients were found to be SARS-CoV 2 PCR positive which were included in the study. Mean age of patients was 39.45+/-31.9 years and majority of the patients in our study were male, i.e., 238 (89.5%). Most common clinical features among COVID-19 symptomatic patients were fever and dry cough followed by myalgias and sore throat. Eighteen (7%) out of 266 died in our setup. Time duration of viral shedding after initial positive PCR varied between 11 days to up to more than 55 days. Conclusion: Coronavirus disease-19 (COVID-19) can present with wide range of clinical spectrum and disease can be life threatening. Severity of disease, requirement of ICU care and mortality were directly related to age of the patient and underlying comorbidities. Rigorous precautionary measures are of utmost importance particularly in this high-risk population.